Conagen and Blue California join forces to bring fermentation-derived functional ingredient for healthy aging

July 30, 2021 | News Commentary

Conagen has scaled up its technology platform to produce nicotinamide mononucleotide (NMN), with plans to commercialize this as a B2B ingredient through Blue California. As a precursor to NAD+, NMN...